# DICE Therapeutics Inc. (DICE) Source: https://www.quantisnow.com/company/DICE Generated: 2026-11-15T16:16:51.805Z - Ticker: DICE - Exchange: NASDAQ - Sector: Health Care - Industry: Biotechnology: Pharmaceutical Preparations - IPO year: 2021 ## Latest DICE news and filings - 2023-08-21 12:00 UTC [SEC Form 15-12G filed by DICE Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-dice-therapeutics-inc-4920041) - 2023-08-11 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by DICE Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-dice-therapeutics-inc-4881344) - 2023-08-09 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Ra Capital Management, L.P.](https://www.quantisnow.com/insight/sec-form-4-filed-by-ra-capital-management-lp-4872377) - 2023-08-09 21:00 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by DICE Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-dice-therapeutics-inc-amendment-4872367) - 2023-08-09 20:38 UTC [SEC Form 4] [SEC Form 4: Tetlow Sharon returned 49,841 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-tetlow-sharon-returned-49841-shares-to-the-4871997) - 2023-08-09 20:36 UTC [SEC Form 4] [SEC Form 4 filed by Simson Jake](https://www.quantisnow.com/insight/sec-form-4-filed-by-simson-jake-4871963) - 2023-08-09 20:33 UTC [SEC Form 4] [SEC Form 4: Scopa James Paul returned 40,921 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-scopa-james-paul-returned-40921-shares-to-4871907) - 2023-08-09 20:31 UTC [SEC Form 4] [SEC Form 4: Robertson Scott M. returned 198,000 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-robertson-scott-m-returned-198000-shares-to-4871866) - 2023-08-09 20:29 UTC [SEC Form 4] [SEC Form 4: Scheller Richard H returned 8,427 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-scheller-richard-h-returned-8427-shares-to-4871751) - 2023-08-09 20:26 UTC [SEC Form 4] [SEC Form 4: Timothy Lu returned 152,285 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-timothy-lu-returned-152285-shares-to-the-4871715) - 2023-08-09 20:25 UTC [SEC Form 4] [SEC Form 4: Judice Kevin returned 799,685 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-judice-kevin-returned-799685-shares-to-the-4871686) - 2023-08-09 20:23 UTC [SEC Form 4] [SEC Form 4: Jacobsen John R. returned 147,497 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-jacobsen-john-r-returned-147497-shares-to-4871638) - 2023-08-09 20:21 UTC [SEC Form 4] [SEC Form 4 filed by Doyle Mittie](https://www.quantisnow.com/insight/sec-form-4-filed-by-doyle-mittie-4871589) - 2023-08-09 20:19 UTC [SEC Form 4] [SEC Form 4 filed by Bowers Lisa](https://www.quantisnow.com/insight/sec-form-4-filed-by-bowers-lisa-4871531) - 2023-08-09 20:00 UTC [Market Insight] [What 9 Analyst Ratings Have To Say About DICE Therapeutics](https://www.quantisnow.com/insight/what-9-analyst-ratings-have-to-say-about-dice-therapeutics-4870656) - 2023-08-09 13:47 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by DICE Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dice-therapeutics-inc-4868300) - 2023-08-09 13:45 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by DICE Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dice-therapeutics-inc-4868292) - 2023-08-09 13:42 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by DICE Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dice-therapeutics-inc-4868279) - 2023-08-09 13:38 UTC [SEC Form POSASR filed by DICE Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-dice-therapeutics-inc-4868262) - 2023-08-09 13:32 UTC [SEC Form POS AM filed by DICE Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-dice-therapeutics-inc-4868222) - 2023-08-09 13:26 UTC [SEC Form 8-K] [DICE Therapeutics Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/dice-therapeutics-inc-filed-sec-form-8-k-termination-of-a-4868167) - 2023-08-09 13:20 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by DICE Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-dice-therapeutics-inc-amendment-4868136) - 2023-08-09 13:14 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by DICE Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-dice-therapeutics-inc-amendment-4868093) - 2023-08-09 13:02 UTC [Mergers & Acquisitions] [Lilly Completes Acquisition of DICE Therapeutics](https://www.quantisnow.com/insight/lilly-completes-acquisition-of-dice-therapeutics-4867976) - 2023-08-09 13:01 UTC [SEC Form 25-NSE filed by DICE Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-dice-therapeutics-inc-4867968) - 2023-08-08 20:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by DICE Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-dice-therapeutics-inc-4863099) - 2023-08-07 12:15 UTC [Market Insight] [Top 5 Health Care Stocks That May Crash In Q3](https://www.quantisnow.com/insight/top-5-health-care-stocks-that-may-crash-in-q3-4852772) - 2023-08-03 23:37 UTC [SEC Form 4] [SEC Form 4: Scopa James Paul gifted 2,420 shares](https://www.quantisnow.com/insight/sec-form-4-scopa-james-paul-gifted-2420-shares-4845714) - 2023-07-25 11:11 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by DICE Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-dice-therapeutics-inc-amendment-4789194) - 2023-07-25 11:04 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by DICE Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-dice-therapeutics-inc-amendment-4789161) - 2023-07-25 10:55 UTC [Lilly Announces Extension of Tender Offer to Acquire DICE](https://www.quantisnow.com/insight/lilly-announces-extension-of-tender-offer-to-acquire-dice-4789012) - 2023-07-19 20:53 UTC [SEC Form 4] [SEC Form 4 filed by Scopa James Paul](https://www.quantisnow.com/insight/sec-form-4-filed-by-scopa-james-paul-4772783) - 2023-07-17 21:23 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by DICE Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-dice-therapeutics-inc-amendment-4762250) - 2023-07-17 21:14 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by DICE Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-dice-therapeutics-inc-amendment-4762154) - 2023-07-17 12:37 UTC [Market Insight] [MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022](https://www.quantisnow.com/insight/moonlakes-potential-sale-stock-price-up-fivefold-since-public-debut-4758958) - 2023-07-13 21:12 UTC [SEC Form 4] [SEC Form 4 filed by Scopa James Paul](https://www.quantisnow.com/insight/sec-form-4-filed-by-scopa-james-paul-4753210) - 2023-07-10 14:20 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by DICE Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-dice-therapeutics-inc-amendment-4735033) - 2023-06-30 20:22 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by DICE Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-dice-therapeutics-inc-4710684) - 2023-06-30 20:06 UTC [SEC Schedule TOT] [SEC Form SC TO-T filed by DICE Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-to-t-filed-by-dice-therapeutics-inc-4710352) - 2023-06-26 15:01 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-june-26-2023-4683169) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/DICE - Earnings history: https://www.quantisnow.com/earnings/DICE - Dividend history: https://www.quantisnow.com/dividends/DICE - Insider transactions: https://www.quantisnow.com/insiders/DICE - Options chain: https://www.quantisnow.com/options/DICE - SEC 8-K filings only: https://www.quantisnow.com/company/DICE/8-k - RSS and alerts for DICE: https://www.quantisnow.com/docs/rss-feeds.md